Anti human papillomavirus vaccine: The checkmate to human papillomavirus?

European Journal of Gynaecological Oncology

Volumn 25, Issue 2, 2004, Pages 151-156

  Moscarini, M ^a   Lukic, A ^a,b   Franco, C ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b NONE   (Italy)

Author keywords

Clinical trial; Human papillomavirus; Vaccine

Indexed keywords

CAPSID PROTEIN; DNA VACCINE; NEUTRALIZING ANTIBODY; PROTEIN E7; PROTEIN L1; PROTEIN L2; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS PROTEIN; VIRUS VACCINE; VIRUS VECTOR; WART VIRUS VACCINE;

ANTIBODY RESPONSE; CANCER SCREENING; CLINICAL TRIAL; CONDYLOMA ACUMINATUM; DENDRITIC CELL; DRUG INDICATION; GENE FUSION; HUMAN; IMMUNOPROPHYLAXIS; INFECTION PREVENTION; MASS SCREENING; NONHUMAN; PROPHYLAXIS; PROTEIN EXPRESSION; REVIEW; SECONDARY PREVENTION; SEXUALLY TRANSMITTED DISEASE; SIDE EFFECT; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VIRUS GENE; VIRUS INFECTION; VIRUS NEUTRALIZATION; VIRUS PARTICLE; WART VIRUS;

FEMALE; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VIRAL VACCINES;

EID: 1442327533     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. Casone A.: "Vaccini e vaccinazioni antinfettive. Accademia Nazionale Medica". Forum Service Editore s.c.a.r.l., 2001.
2. Zur Hausen H.: "Viruses in human cancer". Science, 1991, 254, 1167.
3. Brown D.R., Schroeder J.M., Bryan J.T., Stoler M.H., Fife K.H.: "Detection of multiple human papillomavirus types in condylomata acuminata lesions from otherwise healthy and immunosuppressed patients". J. Clin. Microb., 1999, 37, 3316.
4. WHO: "The current status of development of prophylactic vaccine against human papillomavirus infection". Report of a technical meeting, Geneva, 16-18 February 1999. Department of Vaccines and Other Biologicals. World Health Organization.
5. Bosch F.X., Lorincz A., Munoz N., Meijer C.J.L.M., Shah K.V.: "The causal relation between human papillomavirus and cervical cancer". J. Clin. Pathol., 2002, 55, 244.
6. Stanley M.A., Masterson P.J., Nicholls P.K.: "In vitro and animal models for antiviral therapy for papillomavirus infections". Antiv. Chem. Chemo., 1997, 8, 381.
7. Harro C.D., Pang Y.Y., Roden R.B., Hildesheim A., Wang Z., Reynolds M.J. et al.: "Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine". J. Natl. Cancer Inst., 2001, 3, 284.
8. Schiller J.T., Lowy D.R.: "Papillomavirus-like particle based vaccines: cervical cancer and beyond". Expert. Opin. Biol. Ther., 2001, 4, 571.
9. Evans T.G., Bonnez W., Rose R.C., Rose R.C., Koeig S., Demeter L. et al.: "A phase I study of a recombinant virus-like particle vaccine against human papillomavirus type 11 in healthy adult volunteers". J. Infect. Dis., 2001, 183, 1485.
10. Zhang L.F., Zhou J., Chen S., Cai L.L., Bao Q.Y., Zheng F.Y. et al.: "HPV6b virus like particles are potent immunogens without adjuvant in men". Vaccine, 2000, 18, 1051.
11. Emeny R.T., Wheeler C.M., Jansen K.U., Hunt W.C., Fu T.M., Smith J.F. et al.: "Priming of human papillomavirus type 11-specific humoral and cellular response in college aged women with a virus-like particle vaccine". J. Virol., 2002, 76, 7832.
12. Koutsky L.A., Ault K.A., Wheeler C.M., Brown D.R., Barr E., Alvarez F.B. et al.: "A controlled trial of a human papillomavirus type 16 vaccine". N. Engl. J. Med., 2002, 347, 1645.
13. Muller M., Zhou J., Reed T.D., Rittmuller C., Burger A., Gabelsberger J. et al.: "Chimeric papillomavirus-like particles". Virol., 1997, 234, 93.
14. Peng S., Frazer I.H., Fernando G.J., Zhou J.: "Papillomavirus-like particles can deliver defined CTL epitopes to the MHC class I pathway". Virol., 1998, 240, 147.
15. Borysiewicz L., Fiander A., Nimako M., Man S., Wilkinson G.W., Westmoreland D. et al.: "A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer". Lancet, 1996, 347, 1523.
16. Adams M., Borysiewicz L., Fiander A., Man S., Jasani B., Navabi H. et al.: "Clinical studies of human papillomavirus vaccines in pre-invasive and invasive cancer". Vaccine, 2001, 19, 2549.
17. Van Driel W.J., Ressing M.E., Kenter G.G., Brandt R.M.P., Krul E.J.T., van Rossum A.B. et al.: "Vaccination with HPV16 peptides of patients with advanced cervical carcinoma: clinical evaluation of a phase I-II trial". Eur. J. Cancer, 1999, 35, 946.
18. th International Papillomavirus Conference, Barcelona, Spain. Program and Abstract book (abstr. 380).
19. Muderspach L., Wilczynski S., Roman L., Bade L., Felix J., Small L.A. et al.: "A phase I trial of a human papillomavirus (HPV) peptide vaccine for women with high-grade cervical and vulvar intraepithelial neoplasia who are HPV 16 positive". Clin. Cancer Res., 2000, 6, 3406.
20. Da Silva D., Eiben G.L., Fausch S.C., Wakabayashi M.T., Rudolf M.P., Velders M.P., Dast W.M.: "Cervical cancer vaccines: emerging concepts and developments". J. Cell. Physiol., 2001, 186, 169.
21. Stanley M.A.: "Immunobiology of Papillomavirus infections". J. Reprod. Immunol., 2001, 52, 45.
22. Bamelli C., Roden R.B., Potts A., Schiller J., De Grandi P., Nardeli-Haefliger D.: "Nasal immunization of mice with human papillomavirus type 16 VLP elicits neutralizing antibodies in mucosal secretions". J. Virol., 1998, 72, 8220.
23. Nardeli-Haefliger D., Roden R.B., Benyacoub J., Sahli R., Kraehenbuhl J.P., Schiller J.T. et al.: "Human papillomavirus type 16 VLP expressed in attenuated Salmonella typhimurium elicit mucosal and systemic neutralizing antibodies in mice". Infect. Immunol., 1997, 65, 3328.
24. Duggan-Keen M.F., Brown M.D., Satcey S.N., Stern P.L.: "Papillomavirus vaccines". Front. Biosc., 1998, 3, 1192.
25. Schiller J.T.: "Papillomavirus-like particle vaccines for cervical cancer". Mol. Med. Today, 1999, 5, 209.